(Q37852084)

24 August 2017

title

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. (English)

1 reference

small intestinal bacterial overgrowth

24 August 2017

main subject

0 references

7

A R Zinsmeister

1 reference

24 August 2017

8

N J Talley

1 reference

24 August 2017

William Scott Harmsen

6

object named as

W S Harmsen

1 reference

24 August 2017

R S Choung

1

1 reference

24 August 2017

K C Ruff

2

1 reference

24 August 2017

A Malhotra

3

1 reference

24 August 2017

L Herrick

4

1 reference

24 August 2017

G R Locke

5

1 reference

24 August 2017

Y A Saito

9

1 reference

24 August 2017

language of work or name

English

0 references

publication date

13 March 2011

1 reference

Alimentary Pharmacology & Therapeutics

24 August 2017

published in

1 reference

24 August 2017

volume

33

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

1059-1067

1 reference

Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Intestinal bacterial overgrowth during chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Sensitivity of bile acid breath test in the diagnosis of bacterial overgrowth in the small intestine with and without the stagnant (blind) loop syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Duodenal bacterial overgrowth during treatment in outpatients with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04625.X

10.1111/J.1365-2036.2011.04625.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference